Dasatinib

is a targeted therapy used to treat certain cases of chronic myelogenous leukemia and acute lymphoblastic leukemia. Specifically it is used to treat cases that are Philadelphia chromosome-positive

302964-02-9:

Dasatinib

302964-02-9:

Dasatinib

302964-02-9:

Dasatinib

302964-02-9:

Dasatinib

302964-02-9:

Dasatinib

Specifications:

Intermediate CAS No API/End Use Status Purity
2-(N-BOC)-Aminothiazole-5-carboxylic acid 302964-02-9 Dasatinib Commercial
(E) -N-(2-Chloro-6-Methyl Phenyl)-3-Ethoxy Acrylamide 863127-76-8 Dasatinib Commercial 99.37%
2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide 302964-24-5 Dasatinib Pilot Scale 99.3%
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide 302964-08-5 Dasatinib Lab Scale 98.78%
4,6-dichloro-2-methylpyrimidine 1780-26-3 Dasatinib Commercial 99.93%